Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
MAGE-A4：Afami-cel和ADP-A2M4CD8|滑膜肉瘤|卵巢癌|TCR|CD8|细胞|患者|肿瘤|治疗|疗法|数据|-健康界
FDA Greenlights First Engineered Cell Therapy for a Solid Tumor ...
FDA Grants Accelerated Approval to Afamitresgene Autoleucel (TECELRA ...
SPEAR T细胞 | afami-cel 为实体瘤患者带来|滑膜肉瘤|细胞|肿瘤|抗原|-健康界
SPEAR T细胞 | afami-cel 为实体瘤患者带来希望 - 知乎
TCR-T细胞免疫疗法Afami-cel(Tecelra)在美国获批上市,TCR-T细胞治疗实体瘤患者有救了_全球肿瘤医生网
Detection of afami-cel and T cell phenotypes in patient tumor ...
全球第二款TCR-T疗法ADP-A2M4(Afami-Cel、Afamitresgene Autoleucel)用于治疗滑膜肉瘤有望上市_全球 ...
Novel T cell receptor therapy afami-cel shows early anti-tumor activity ...
(PDF) Abstract A023: Identifying new therapeutic indications for ...
Adaptimmune Receives U.S. FDA Accelerated Approval of TECELRA ...
读书报告 | Afamitresgene autoleucel治疗晚期滑膜肉瘤和黏液样圆细胞脂肪肉瘤的开放标签2期试验-MedSci.cn
FDA Gives Priority Review to Afami-Cel in Advanced Synovial Sarcoma ...
易前沿 | 全球首款TCR-T疗法Afami-cel滚动上市，滑膜肉瘤将迎来新疗法 - 知乎
FDA Accelerates Approval of Afamitresgene Autoleucel for Advanced ...
Optimal Timing for Introducing Afami-Cel Therapy in the Treatment Journey
Afami-cel: First T-Cell Therapy Approved for Solid Tumors
Nature杂志重磅消息:TCR-T细胞疗法Afami-Cel疾病控制率高达74%,对多种癌症有效_全球肿瘤医生网
TECELRA® (afami-cel) is the first TCR-T cell therapy for solid tumors ...
FDA接受Afami-cel治疗晚期滑膜肉瘤的生物制品许可申请，并优先审查-上市-医保-临床适应症-香港济民药业
The FDA has approved the first engineered T cell therapy, afami-cel ...
FDA Accepts BLA for Afami-Cel for Priority Review as Treatment of ...
Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round ...
Afamitresgene Autoleucel, First Gene Therapy to Treat Adults With ...
FDA Approves Adaptimmune’s TCR T-cell Therapy Afami-cel for Synovial ...
FDA accepts Adaptimmune’s BLA for afami-cel for synovial sarcoma | The ...
Afamitresgene Autoleucel Elicits Impressive Responses in Synovial Sarcoma
Adaptimmune’s Afami-cel is the first FDA-approved T-cell receptor ...
afamitresgene autoleucel (ADP-A2M4) / Adaptimmune
FDA Grants Accelerated Approval to Afami-Cel for Advanced Synovial Sarcoma
Afami-cel Demonstrates Enduring Responses in Pretreated Synovial Sarcoma
How Afami-Cel Immunotherapy Helped a Young Man With Stage 4 Synovial ...
FDA Approves First Engineered Cell Therapy for a Solid Tumor FDA ...
潜在首款！Adaptimmune癌症TCR-T细胞疗法afami-cel关键试验结果登《柳叶刀》
TCR-T细胞疗法治疗实体瘤无瘤生存超9年,成为新一代抗癌利器,预计8月首款产品上市_全球肿瘤医生网
Abstract A023: Identifying new therapeutic indications for ...
里程碑！全球首款TCR-T细胞疗法申报上市
Afamitresgene autoleucel (afami-cel) - News, Articles etc. - European ...
Tecelra|Afamitresgene Autoleucel|afami-cel|ADP-A2M4——药研档案
Afami-cel Granted Accelerated Approval for Advanced Synovial Sarcoma
Afami-cel: A new T-cell immunotherapy for synovial sarcoma | Bichoy ...
新型TCR-T疗法Afami-cel获FDA优先评审资格_全球肿瘤医生网
FDA Approves Adaptimmune's Afami-cel Submission for Advanced Synovial ...
The FDA has approved a cellular therapy called afamitresgene autoleucel ...
Adaptimmune Completes Submission of Rolling Biologics License ...
实体肿瘤针对MAGE-A4抗原的TCR-T细胞治疗,TCR-T细胞疗法ADP-A2M4 T细胞免疫疗法横空出世-无癌家园
FDA Approval of Afamitresgene Autoleucel for Sarcoma May Change Cancer ...
Newly Approved Cell Therapy Afami-Cel Shows Long-Term Tumor Control in ...
Here to Stay: Progress Solidifies the Future of Cell Therapy
Afami-cel Approval May Open Gateway for Synovial Sarcoma Advancements
2024年有望上市的CAR-T疗法、TIL疗法、TCR-T疗法多款细胞产品,攻克血液肿瘤及实体瘤的号角已吹响-无癌家园
FDA Grants Accelerated Approval for Afami-Cel in Treatment of Advanced ...
Tricuspid Valve Replacement System, Afami-Cel for Synovial Sarcoma ...
SPEARHEAD-1: a single-arm phase 2 trial of afamitresgene autoleucel ...
Adaptimmune Announces U.S. FDA Acceptance of Biologics License ...
FDA Approval Insights: Afami-Cel for Pretreated, Unresectable or ...
FDA Grants Afami-cel Accelerated Approval in Advanced Synovial Sarcoma
Afami-cel’s Mechanism of Action and Role in Synovial Sarcoma | Targeted ...
New Hope On The Horizon For Advanced Synovial Sarcoma | Faculty of Medicine
滑膜肉瘤新疗法！TCR-T疗法afami-cel的临床数据及不良反应！-印塔健康官网
Afamitresgene autoleucel in advanced synovial sarcoma and myxoid round ...
Afamitresgene Autoleucel Induces Durable Clinical Response in Advanced ...
afammi-cel-sarcoma
How Adaptimmune's T-Cell Therapy Development Pipeline Became a ...
New FDA approval for afami-cel gene therapy | Sam Gibbons posted on the ...
New Research Synovial Sarcoma Treatment - Cancer Education and Research ...
Afami-cel - first T CELL THERAPY for SOLID TUMORS #fda #news # ...
Afamitresgene Autoleucel用于治疗晚期滑膜肉瘤_祺昌医药有限公司_香港祺昌大药房
Adaptimmune's Afami-cel Receives FDA Accelerated Approval - CTOL ...
重磅！FDA批准首款TCR-T细胞疗法_腾讯新闻
The FDA approval of afami-cel is a powerful reminder of what’s possible ...
Afami-cel对晚期滑膜肉瘤和粘液样圆细胞脂肪肉瘤具有治疗效果_海得康海外新特药
潜在首款！Adaptimune实体瘤TCR-T疗法afami-cel的BLA申请获FDA优先审评资格
TCR-T细胞疗法Tecelra（afami-cel）治疗滑膜肉瘤的临床数据
Behind the FDA Approval: Afami-Cel in Synovial Sarcoma | Targeted ...
Will Adaptimmune's Afami-cel End The Decade-Long Wait In Synovial ...
“Exciting” Response Durability Data Support Afami-cel Approval in Sarcoma
Afami-cel治疗晚期滑膜肉瘤和黏液样圆细胞脂肪肉瘤的研究效果_海得康海外新特药
Addressing Potential Barriers to the Adoption of Afami-Cel Therapy ...
FDA优先审查Afami-cel治疗晚期滑膜肉瘤的生物制品许可申请 | 香港致泰药业
A Food and Drug Administration (FDA) dos Estados Unidos aprovou o ...
Afami-Cel Shows Durable Persistence and Tumor-Killing Abilities in ...
#fda #viralvector #genetherapy #solidtumors #talimogene #tvec #melanoma ...
